<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="wjo287" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Otorhinolaryngol Head Neck Surg</journal-id><journal-id journal-id-type="iso-abbrev">World J Otorhinolaryngol Head Neck Surg</journal-id><journal-id journal-id-type="pmc-domain-id">3346</journal-id><journal-id journal-id-type="pmc-domain">wjohns</journal-id><journal-id journal-id-type="publisher-id">WJO2</journal-id><journal-title-group><journal-title>World Journal of Otorhinolaryngology - Head and Neck Surgery</journal-title></journal-title-group><issn pub-type="ppub">2095-8811</issn><issn pub-type="epub">2589-1081</issn><publisher><publisher-name>Chinese Medical Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10296052</article-id><article-id pub-id-type="pmcid-ver">PMC10296052.1</article-id><article-id pub-id-type="pmcaid">10296052</article-id><article-id pub-id-type="pmcaiid">10296052</article-id><article-id pub-id-type="pmid">37383327</article-id><article-id pub-id-type="doi">10.1002/wjo2.87</article-id><article-id pub-id-type="publisher-id">WJO287</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Paper</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Papers</subject></subj-group></article-categories><title-group><article-title>A retrospective analysis of pain and opioid usage in head and neck free flap reconstruction</article-title><alt-title alt-title-type="right-running-head">PAIN AND OPIOIDS IN HEAD AND NECK FREE FLAP</alt-title><alt-title alt-title-type="left-running-head">TOWFIGHI <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="wjo287-cr-0001" contrib-type="author"><name name-style="western"><surname>Towfighi</surname><given-names initials="P">Parhom</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2192-1143</contrib-id><xref rid="wjo287-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="wjo287-cr-0002" contrib-type="author"><name name-style="western"><surname>Hill</surname><given-names initials="A">Alison</given-names></name><xref rid="wjo287-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="wjo287-cr-0003" contrib-type="author" corresp="yes"><name name-style="western"><surname>Crossley</surname><given-names initials="JR">Jason R.</given-names></name><xref rid="wjo287-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>Jason.R.Crossley@medstar.net</email></address></contrib><contrib id="wjo287-cr-0004" contrib-type="author"><name name-style="western"><surname>Walsh</surname><given-names initials="A">Amanda</given-names></name><xref rid="wjo287-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="wjo287-cr-0005" contrib-type="author"><name name-style="western"><surname>Leonard</surname><given-names initials="JA">James A.</given-names></name><xref rid="wjo287-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="wjo287-cr-0006" contrib-type="author"><name name-style="western"><surname>Giurintano</surname><given-names initials="JP">Jonathan P.</given-names></name><xref rid="wjo287-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="wjo287-cr-0007" contrib-type="author"><name name-style="western"><surname>Pierce</surname><given-names initials="ML">Matthew L.</given-names></name><xref rid="wjo287-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="wjo287-cr-0008" contrib-type="author"><name name-style="western"><surname>Reilly</surname><given-names initials="MJ">Michael J.</given-names></name><xref rid="wjo287-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="wjo287-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Georgetown University School of Medicine</institution>
<city>Washington</city>
<named-content content-type="country-part">District of Columbia</named-content>
<country country="US">USA</country>
</aff><aff id="wjo287-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Otolaryngology&#8212;Head and Neck Surgery</named-content>
<institution>Medstar Georgetown</institution>
<city>Washington</city>
<named-content content-type="country-part">District of Columbia</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Jason R. Crossley, Department of Otolaryngology&#8212;Head and Neck Surgery, MedStar Georgetown University Hospital, 3800 Reservoir Rd, NW, Washington, DC 20007, USA.<break/>
Email: <email>Jason.R.Crossley@medstar.net</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>1</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2023</year></pub-date><volume>9</volume><issue seq="80">2</issue><issue-id pub-id-type="pmc-issue-id">439211</issue-id><issue-id pub-id-type="doi">10.1002/wjo2.v9.2</issue-id><fpage>153</fpage><lpage>159</lpage><history><date date-type="rev-recd"><day>07</day><month>10</month><year>2022</year></date><date date-type="received"><day>06</day><month>3</month><year>2022</year></date><date date-type="accepted"><day>28</day><month>10</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>01</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>28</day><month>06</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-20 09:26:29.733"><day>20</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. <italic toggle="yes">World Journal of Otorhinolaryngology &#8208; Head and Neck Surgery</italic> published by John Wiley &amp; Sons Ltd on behalf of Chinese Medical Association.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="WJO2-9-153.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:WJO2-9-153.pdf"/><abstract><title>Abstract</title><sec id="wjo287-sec-0010"><title>Objectives</title><p>Investigate opioid usage and postoperative pain in patients undergoing head and neck free flap surgery.</p></sec><sec id="wjo287-sec-0020"><title>Methods</title><p>A retrospective review of 100 consecutive patients undergoing head and neck free flap reconstruction at two academic centers was performed. Data captured included demographics, postoperative inpatient pain, pain at postoperative visits, morphine equivalent doses (MEDs) administration, medication history, and comorbidities. Data were analyzed using regression models, <italic toggle="yes">&#967;</italic>
<sup>2</sup> tests, and student's <italic toggle="yes">t</italic>&#8208;tests.</p></sec><sec id="wjo287-sec-0030"><title>Results</title><p>Seventy&#8208;three percent of patients were discharged with opioid medication, with over half (53.4%) continuing to take opioids at their second postoperative visit, and over one&#8208;third (34.2%) continuing to take them around 4&#8208;month&#160;postoperatively. One out of every five (20.3%) opioid&#8208;na&#239;ve patients chronically took opioids postoperatively. There was a poor association between inpatient postoperative pain scores and daily MEDs administered (<italic toggle="yes">R</italic>
<sup>2</sup>&#8201;=&#8201;0.13, 0.17, and 0.22 in postoperative Days 3, 5, and 7, respectively). Neither preoperative radiotherapy nor postoperative complications were associated with an increase in opioid usage.</p></sec><sec id="wjo287-sec-0040"><title>Conclusions</title><p>For patients undergoing head and neck free flap operations, opioid medications are commonly used for postoperative analgesia. This practice may increase the chance an opioid&#8208;na&#239;ve patient uses opioids chronically. We found a poor association between MEDs administered and patient&#8208;reported pain scores, which suggests that standardized protocols aimed at optimizing analgesia while reducing opioid administration may be warranted.</p><p>
<bold>Level of Evidence:</bold> 3 (Retrospective cohort study).</p></sec></abstract><kwd-group><kwd id="wjo287-kwd-0001">free flap reconstruction</kwd><kwd id="wjo287-kwd-0002">head and neck</kwd><kwd id="wjo287-kwd-0003">multimodal analgesia</kwd><kwd id="wjo287-kwd-0004">opioids</kwd><kwd id="wjo287-kwd-0005">postoperative pain</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="0"/><table-count count="4"/><page-count count="7"/><word-count count="4555"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.9 mode:remove_FC converted:27.06.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="wjo287-cit-0033"><string-name name-style="western"><surname>Towfighi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Crossley</surname><given-names>JR</given-names></string-name>, et al. <article-title>A retrospective analysis of pain and opioid usage in head and neck free flap reconstruction</article-title>. <source>World J Otorhinolaryngol Head Neck Surg</source>. <year>2023</year>;<volume>9</volume>:<fpage>153</fpage>&#8208;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1002/wjo2.87</pub-id><pub-id pub-id-type="pmcid">PMC10296052</pub-id><pub-id pub-id-type="pmid">37383327</pub-id></mixed-citation>
</p></notes></front><body><sec id="wjo287-sec-0050"><title>INTRODUCTION</title><p>Pain is multifactorial and defined by several features such as personal experience, quality perception, location, intensity, and emotional impact.<xref rid="wjo287-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Managing postoperative pain, thus, is a multifaceted issue that is dependent on the patient, provider, specific institution, and national guidelines.<xref rid="wjo287-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Patients undergoing head and neck surgery requiring free flap reconstruction often suffer from postoperative pain. This pain can be poorly controlled and may limit early mobilization and ambulation, putting patients at increased risk for complications.<xref rid="wjo287-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> One of the main options for postoperative pain control in this group of patients is the use of opioid analgesics, which have a variety of undesirable side effects. In addition, these patients are often discharged with a liberal number of opioid analgesics, which contributes to the overall burden of available medication in the opioid epidemic.<xref rid="wjo287-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> According to the Centers for Disease Control and Prevention, nearly 247,000 individuals died from prescription opioids in the United States from 1999 to 2019,<xref rid="wjo287-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> and those at the highest risk of opioid overdose are as likely to receive opioid medication from their clinician as they are from a friend or family member.<xref rid="wjo287-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p><p>Multimodal analgesia (MMA) is a method of pain control that combines various classes of medication for pain relief. Due to their ability to reduce opioid use and associated risks, MMA protocols are gaining popularity; however, limited published guidance on their use compared to opioid medication has created variability in physician prescribing patterns.<xref rid="wjo287-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="wjo287-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="wjo287-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Specifically, data on MMA for the management of postoperative pain in patients undergoing head and neck free flap surgery are&#160;limited. A recent systematic review comparing MMA versus standard opioid&#8208;based pain management protocols found that an MMA protocol had equal efficacy in treating postoperative pain without the risk of postoperative morbidity in the head and neck free flap surgery population, although the number of individual studies remains low.<xref rid="wjo287-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> In this study, we investigate postoperative pain and opioid usage in patients undergoing head and neck free flap reconstructive surgery.</p></sec><sec sec-type="methods" id="wjo287-sec-0060"><title>METHODS</title><p>A retrospective chart review was performed on 100 consecutive patients who underwent head and neck free flap reconstruction at two academic centers from July 2018 to January 2021. All patients who underwent head and neck free flap reconstruction at these centers during this interval were included in this study. Patients whose clinical documentation lacked pain scores or analgesic data were excluded, which totaled to two patients. Free flap procedures were performed by head and neck reconstructive physicians and included radial forearm&#8208;free flaps, anterolateral thigh&#8208;free flaps, fibula&#8208;free flaps, and scapula&#8208;free flaps. Ninety&#8208;one patients had a preoperative diagnosis of head and neck squamous cell carcinoma (SCC) before head and neck reconstruction, with the remaining nine having either a structural deformity, non&#8208;SCC head and neck tumor, osteoradionecrosis, or osteomyelitis. Data collected include postoperative pain scores, morphine equivalent doses (MEDs) administration, demographics, smoking history, outpatient visit pain scores, daily MEDs provided at discharge, medical comorbidities, and postsurgical complications (Tables&#160;<xref rid="wjo287-tbl-0001" ref-type="table">1</xref>&#160;and&#160;<xref rid="wjo287-tbl-0002" ref-type="table">2</xref>). The continuous use of opioids at postoperative outpatient visits was based on medication reconciliation performed at each visit. Data were analyzed using Student's <italic toggle="yes">t</italic>&#8208;tests, <italic toggle="yes">&#967;</italic>
<sup>2</sup> tests, one&#8208;way analysis of variance, and regression models. Statistical analysis was performed via online software (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.socscistatistics.com/" ext-link-type="uri">https://www.socscistatistics.com/</ext-link>), and significance was set to values of <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05<italic toggle="yes">.</italic> This study received relevant institutional board review approval.</p><table-wrap position="float" id="wjo287-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Patent demographics</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="bottom" rowspan="1" colspan="1">Value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">No. of patients</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Male</td><td align="left" valign="top" rowspan="1" colspan="1">64</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Female</td><td align="left" valign="top" rowspan="1" colspan="1">36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Mean&#8201;&#177;&#8201;SD</td><td align="left" valign="top" rowspan="1" colspan="1">61.8&#8201;&#177;&#8201;13.3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Range</td><td align="left" valign="top" rowspan="1" colspan="1">2&#8211;87</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">White</td><td align="left" valign="top" rowspan="1" colspan="1">58</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Black</td><td align="left" valign="top" rowspan="1" colspan="1">33</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Asian/Asian American</td><td align="left" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other</td><td align="left" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comorbidities</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">DM</td><td align="left" valign="top" rowspan="1" colspan="1">19</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">COPD</td><td align="left" valign="top" rowspan="1" colspan="1">9</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CHF</td><td align="left" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CAD/MI</td><td align="left" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">HTN</td><td align="left" valign="top" rowspan="1" colspan="1">50</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Asthma</td><td align="left" valign="top" rowspan="1" colspan="1">11</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Dementia/delirium</td><td align="left" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Depression/anxiety</td><td align="left" valign="top" rowspan="1" colspan="1">17</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Alcohol use disorder</td><td align="left" valign="top" rowspan="1" colspan="1">16</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Substance user disorder</td><td align="left" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Previous/current smokers</td><td align="left" valign="top" rowspan="1" colspan="1">68</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of previous head and neck radiotherapy</td><td align="left" valign="top" rowspan="1" colspan="1">39</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of previous head and neck surgery</td><td align="left" valign="top" rowspan="1" colspan="1">47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Prior opioid use preoperatively</td><td align="left" valign="top" rowspan="1" colspan="1">31</td></tr></tbody></table><table-wrap-foot><fn id="wjo287-tbl1-note-0001"><p>Abbreviations: CAD/MI, coronary artery disease/myocardial infarction; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; SD, standard deviation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="wjo287-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Surgical details</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="bottom" rowspan="1" colspan="1">Value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Preoperative comorbid risk (MFI&#8208;5 Score)</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">40</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">38</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">21</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Primary tumor/defect location</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Oral cavity</td><td align="left" valign="top" rowspan="1" colspan="1">48</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Oropharynx</td><td align="left" valign="top" rowspan="1" colspan="1">12</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Larynx</td><td align="left" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypopharynx</td><td align="left" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Parotid</td><td align="left" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sinonasal</td><td align="left" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Maxilla</td><td align="left" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Scalp/facial skin</td><td align="left" valign="top" rowspan="1" colspan="1">13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Free flap type</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Radial forearm</td><td align="left" valign="top" rowspan="1" colspan="1">27</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Anterolateral thigh</td><td align="left" valign="top" rowspan="1" colspan="1">37</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Fibular</td><td align="left" valign="top" rowspan="1" colspan="1">29</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Scapular</td><td align="left" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postoperative hospital length of stay (days)</td><td align="left" valign="top" rowspan="1" colspan="1">11.7&#8201;&#177;&#8201;6.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postoperative surgical complications</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hematoma/seroma</td><td align="left" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Wound dehiscence</td><td align="left" valign="top" rowspan="1" colspan="1">9</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Wound infection</td><td align="left" valign="top" rowspan="1" colspan="1">18</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Fistula formation</td><td align="left" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Free flap failure</td><td align="left" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Return to OR within 30 days</td><td align="left" valign="top" rowspan="1" colspan="1">16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Clavien&#8208;Dindo</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">I</td><td align="left" valign="top" rowspan="1" colspan="1">79</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">II</td><td align="left" valign="top" rowspan="1" colspan="1">12</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">III</td><td align="left" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IV</td><td align="left" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postoperative medical complications</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">VTE</td><td align="left" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MI</td><td align="left" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CVA</td><td align="left" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sepsis</td><td align="left" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">UTI</td><td align="left" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Readmission within 30 days of discharge</td><td align="left" valign="top" rowspan="1" colspan="1">14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Usage of skin graft</td><td align="left" valign="top" rowspan="1" colspan="1">44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Operative time (min)</td><td align="left" valign="top" rowspan="1" colspan="1">671&#8201;&#177;&#8201;152</td></tr></tbody></table><table-wrap-foot><fn id="wjo287-tbl2-note-0001"><p>Abbreviations: CVA, cerebrovascular accident; MFI&#8208;5, modified 5&#8208;item frailty index; MI, myocardial infarction; OR, operating room; UTI, urinary tract infection; VTE, venous thromboembolism.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec sec-type="results" id="wjo287-sec-0070"><title>RESULTS</title><p>Of the 100 total patients, 73 were discharged with opioid analgesics. Of these patients, 72.6% (<italic toggle="yes">n</italic>&#8201;=&#8201;53) had continued to take opioids by the time of their first postoperative visit, 53.4% (<italic toggle="yes">n</italic>&#8201;=&#8201;39) had continued by the time of their second postoperative visit, and 34.2% (<italic toggle="yes">n</italic>&#8201;=&#8201;25) had continued by the time of their third postoperative visit, which on average occurred 22.2, 43.9, and 115.2 days postoperatively, respectively.</p><p>Preoperatively, 69 patients were opioid&#8208;na&#239;ve, of whom 49 (71%) were discharged with opioid medication. Among the preoperatively opioid&#8208;na&#239;ve patients, 43.5% (<italic toggle="yes">n</italic>&#8201;=&#8201;30), 33.3% (<italic toggle="yes">n</italic>&#8201;=&#8201;23), and 20.3% (<italic toggle="yes">n</italic>&#8201;=&#8201;14) were taking opioid medication at their first, second, and third postoperative visits, respectively. Of the 31 patients taking opioids preoperatively, 77.4% (<italic toggle="yes">n</italic>&#8201;=&#8201;24) were discharged with opioid medication. Of these 31 patients who had been taking opioids preoperatively, 74.2% (<italic toggle="yes">n</italic>&#8201;=&#8201;23), 51.6% (<italic toggle="yes">n</italic>&#8201;=&#8201;16), and 35.5% (<italic toggle="yes">n</italic>&#8201;=&#8201;11) were taking opioid medication at their first, second, and third postoperative visits, respectively.</p><p>There was no significant difference in postoperative opioid usage at the time of discharge between patients who were or were not taking opioids preoperatively (<italic toggle="yes">p</italic>&#8201;=&#8201;0.505). Patients who took opioids preoperatively were taking opioids at their first postoperative visit at a significantly higher rate than those who were opioid&#8208;na&#239;ve (<italic toggle="yes">p</italic>&#8201;=&#8201;0.004); however, opioid usage at the second postoperative visit was not significantly different between groups (<italic toggle="yes">p</italic>&#8201;=&#8201;0.083). By the third postoperative visit, there was no significant difference in opioid usage between opioid&#8208;na&#239;ve and chronic opioid users (<italic toggle="yes">p</italic>&#8201;=&#8201;0.105).</p><p>There was a low correlation between average daily inpatient pain scores and average daily MEDs administered in the first three, five, and seven postoperative days (<italic toggle="yes">R</italic>
<sup>2</sup>&#8201;=&#8201;0.13, 0.17, and 0.22, respectively). Average daily inpatient pain scores were significantly higher in those who were prescribed opioid analgesics at discharge versus those who were not prescribed them (<italic toggle="yes">p</italic>&#8201;=&#8201;0.0006). The average daily inpatient pain scores were also significantly higher in patients who had continued to take opioid analgesia at their first and second postoperative visits than those who were not prescribed opioid analgesics at discharge (<italic toggle="yes">p</italic>&#8201;=&#8201;0.0002; <italic toggle="yes">p</italic>&#8201;=&#8201;0.0001, respectively). At the time of the first and second postoperative outpatient visits, patients who continued to take opioid analgesics had significantly higher outpatient pain scores than patients who were not taking opioid analgesics (Table&#160;<xref rid="wjo287-tbl-0003" ref-type="table">3</xref>; <italic toggle="yes">p</italic>&#8201;=&#8201;0.0048; <italic toggle="yes">p</italic>&#8201;=&#8201;0.0019, respectively).</p><table-wrap position="float" id="wjo287-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Association of inpatient and outpatient pain scores with opioid use at discharge and postoperatively</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Cohort</th><th align="left" valign="bottom" rowspan="1" colspan="1">Average inpatient pain score</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients prescribed opioids at discharge</td><td align="left" valign="top" rowspan="1" colspan="1">3.65&#8201;&#177;&#8201;1.72</td><td align="left" valign="top" rowspan="1" colspan="1">0.0006</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients not prescribed opioid at discharge</td><td align="left" valign="top" rowspan="1" colspan="1">2.37&#8201;&#177;&#8201;1.27</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients continuing opioid intake at POV1</td><td align="left" valign="top" rowspan="1" colspan="1">3.86&#8201;&#177;&#8201;1.81</td><td align="left" valign="top" rowspan="1" colspan="1">0.0002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients not taking opioids at POV1</td><td align="left" valign="top" rowspan="1" colspan="1">2.37&#8201;&#177;&#8201;1.27</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients continuing opioid intake at POV2</td><td align="left" valign="top" rowspan="1" colspan="1">4.01&#8201;&#177;&#8201;1.75</td><td align="left" valign="top" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients not taking opioids at POV2</td><td align="left" valign="top" rowspan="1" colspan="1">2.37&#8201;&#177;&#8201;1.27</td><td valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Cohort</th><th align="left" valign="bottom" rowspan="1" colspan="1">Outpatient visit pain score</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients continuing opioid intake at POV1</td><td align="left" valign="top" rowspan="1" colspan="1">3.32&#8201;&#177;&#8201;3.20</td><td align="left" valign="top" rowspan="1" colspan="1">0.0048</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients not taking opioids at POV1</td><td align="left" valign="top" rowspan="1" colspan="1">1.37&#8201;&#177;&#8201;2.29</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients continuing opioid intake at POV2</td><td align="left" valign="top" rowspan="1" colspan="1">2.89&#8201;&#177;&#8201;3.43</td><td align="left" valign="top" rowspan="1" colspan="1">0.0019</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients not taking opioids at POV2</td><td align="left" valign="top" rowspan="1" colspan="1">1.19&#8201;&#177;&#8201;2.15</td><td valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="wjo287-tbl3-note-0001"><p>Abbreviation: POV, postoperative visit.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Patients who suffered postoperative surgical complications (<italic toggle="yes">n</italic>&#8201;=&#8201;31) were no more likely to be discharged with opioid analgesia than those without postoperative surgical complications (<italic toggle="yes">p</italic>&#8201;=&#8201;0.094). Patients who suffered postoperative surgical complications were no more likely to be taking opioid medications at their first (<italic toggle="yes">p</italic>&#8201;=&#8201;0.496), second (<italic toggle="yes">p</italic>&#8201;=&#8201;0.397), and third (<italic toggle="yes">p</italic>&#8201;=&#8201;0.532) postoperative visits compared to those without postoperative surgical complications.</p><p>Patients with a history of preoperative head and neck radiotherapy (Table&#160;<xref rid="wjo287-tbl-0001" ref-type="table">1</xref>; <italic toggle="yes">n</italic>&#8201;=&#8201;39) were also no more likely to be discharged with opioid analgesia than those without a history of preoperative head and neck radiotherapy (<italic toggle="yes">p</italic>&#8201;=&#8201;0.499). Additionally, there was no significant difference in MEDs per day prescribed at discharge between patients with a history of preoperative radiotherapy and those without (64.6 vs. 43.9; <italic toggle="yes">p</italic>&#8201;=&#8201;0.17). Patients with preoperative radiotherapy were no more likely to be taking opioid medications at their first (<italic toggle="yes">p</italic>&#8201;=&#8201;0.89), second (<italic toggle="yes">p</italic>&#8201;=&#8201;0.93), and third (<italic toggle="yes">p</italic>&#8201;=&#8201;0.19) postoperative visits compared to patients without preoperative radiotherapy.</p><p>Daily pain scores (<italic toggle="yes">p</italic>&#8201;=&#8201;0.318) and daily inpatient MEDs administered (<italic toggle="yes">p</italic>&#8201;=&#8201;0.708) were not significantly different between patients receiving skin grafts or not. The location of the primary tumor/pathology and the operative site had no influence on average inpatient pain scores (<italic toggle="yes">f</italic>&#8208;ratio&#8201;=&#8201;0.940; <italic toggle="yes">p</italic>&#8201;=&#8201;0.446). Tumors located in the hypopharynx, however, were associated with higher average daily inpatient MEDs administered compared to tumors/pathologies found in the oropharynx (54.70 vs. 18.59; <italic toggle="yes">p</italic>&#8201;=&#8201;0.023) and maxilla (54.70 vs. 8.84; <italic toggle="yes">p</italic>&#8201;=&#8201;0.002); no other significant associations were found between other operative locations. Free flap donor site was also not associated with average inpatient pain scores (<italic toggle="yes">f</italic>&#8208;ratio&#8201;=&#8201;1.087; <italic toggle="yes">p</italic>&#8201;=&#8201;0.358) nor average daily inpatient MEDs administered (<italic toggle="yes">f</italic>&#8208;ratio&#8201;=&#8201;1.899; <italic toggle="yes">p</italic>&#8201;=&#8201;0.135) (Supporting Information: Table&#160;<xref rid="wjo287-suppl-0001" ref-type="supplementary-material">1</xref>).</p></sec><sec sec-type="discussion" id="wjo287-sec-0080"><title>DISCUSSION</title><p>Physician prescriptions for opioid analgesics greatly contribute to the opioid epidemic by creating a household supply of these medications that may eventually be misused. Postoperative pain from head and neck free flap reconstructive surgery is often managed by opioids that are continued for weeks postoperatively. Importantly, while studies have shown promise in the use of MMA for postoperative pain control in patients undergoing head and neck free flap surgery, reporting outcomes are variable, making standardized guidelines difficult to create.<xref rid="wjo287-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Our study demonstrates that most patients undergoing head and neck reconstruction surgery are discharged with opioid analgesia, of whom a significant portion continues to take opioid medications chronically, as defined by opioid use over 45 days during a 90&#8208;day period.<xref rid="wjo287-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> In our cohort, over half continue to take opioids 6&#8208;week&#160;postoperatively, and over one&#8208;third continue to take them almost four months postoperatively. Overall, regardless of preoperative opioid consumption status, one out of every four patients undergoing head and neck free flap reconstruction continues to take opioid medication 4 months postoperatively. Among&#160;opioid&#8208;na&#239;ve patients, one out of every five continues to take opioid medications 4 months postoperatively. While chronic opioid usage postoperatively may not be surprising in chronic opioid users, this data may demonstrate that postoperative opioid administration may contribute to chronic opioid usage in opioid&#8208;na&#239;ve patients. We found that higher inpatient postoperative pain is associated with ongoing opioid usage after discharge. However, inpatient pain scores and inpatient MEDs administered were poorly correlated, which calls into question opioid prescribing patterns based on perceived pain severity. This finding indicates that improving inpatient pain control, possibly through nonopioid analgesics, may be one way to reduce ongoing opioid use in outpatients. The WHO Analgesic Ladder promotes that moderate pain (which is defined as pain between 4 and 7 out of 10) be controlled with weak opioid usage<xref rid="wjo287-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>; however, because the overall average daily pain in both groups was relatively low (&lt;4 out of 10), greater emphasis on controlling patient pain while minimizing opioid use may be warranted.</p><p>We found that patients with postoperative surgical complications were no more likely to be discharged with opioid medications compared to patients without postoperative surgical complications. Additionally, postoperative surgical complications were not associated with an increase in opioid analgesia use at postoperative visits. Previous studies have demonstrated an association between postoperative complications and pain after surgery,<xref rid="wjo287-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> which prompts physicians to provide adequate analgesia appropriately to suffering patients; however, our data shows that postoperative complications in the setting of head and neck free flap reconstruction do not impact postoperative opioid usage. There was also no association between preoperative head and neck radiotherapy in opioid prescription rates and postoperative outpatient opioid usage. Because the majority of patients in our cohort had a preoperative diagnosis of head and neck cancer, disease burden may have been hypothesized to impact pain in the postoperative setting. In fact, our cohort demonstrates that there is almost a 50% increase in discharge MEDs per day prescribed to patients with a history of preoperative radiotherapy compared to those without a history of preoperative radiotherapy. While the data are not statistically significant, it is understandable that the disease burden of head and neck cancer in the setting of free flap reconstruction has a potential impact on postoperative pain. Additionally, our data suggest that primary tumor location does not contribute to differences in daily inpatient pain scores, yet patients with primary tumors in the hypopharynx tend to receive more inpatient MEDs than patients with primary tumors in the maxillary and oropharyngeal regions. While the reasoning behind these findings is not entirely clear, it does further allude to the discordance seen in postoperative pain and MEDs administered. Finally, free flap donor sites do not seem to significantly alter postoperative pain and narcotic administration in the inpatient setting, which may help elucidate any potential fallacies regarding seemingly more painful free flap donor sites.</p><p>The invasiveness of head and neck reconstruction greatly impacts postoperative narcotic usage, and patient&#8208;reported outcomes have demonstrated that tumor resection within the oral cavity is one of the most painful procedures in otolaryngology.<xref rid="wjo287-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> MMA protocols have picked up traction in many surgical specialties particularly due to their demonstrated efficacy in controlling postoperative pain as well as decreasing opioid abuse.<xref rid="wjo287-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="wjo287-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> In head and neck surgery, MMA protocols have also been shown to minimize postoperative pain and opioid usage; however, outcomes on postoperative pain have varied among&#160;studies.<xref rid="wjo287-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="wjo287-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="wjo287-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="wjo287-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="wjo287-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="wjo287-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="wjo287-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="wjo287-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="wjo287-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="wjo287-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Some studies have shown that the use of ketamine, acetaminophen, gabapentin, and/or celecoxib provides significant pain relief comparable to opioid usage postoperatively.<xref rid="wjo287-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="wjo287-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="wjo287-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> One specific study used an MMA protocol consisting of preoperative gabapentin and acetaminophen, intraoperative acetaminophen, and postoperative gabapentin, acetaminophen, celecoxib, and ketorolac.<xref rid="wjo287-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> At our center, we have adopted an MMA protocol (Table&#160;<xref rid="wjo287-tbl-0004" ref-type="table">4</xref>) for head and neck free flap patients, with preliminary data suggesting successful postoperative analgesia with a reduction in opioid usage. Our patient cohort in this study consists of the 100 most recent patients receiving head and neck free flap reconstruction before the implementation of our center's MMA protocol. We believe that all patients in our study cohort would have benefited from the usage of an MMA protocol, given that other recent studies have demonstrated efficacy in the head and neck free flap reconstruction patient population. At our center, we use a similar regimen as described by Eggerstedt et al.<xref rid="wjo287-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> with success. Gabapentin has been shown to be an effective means of postoperative pain control in the inpatient setting,<xref rid="wjo287-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> as well as decrease the incidence of opioid usage postoperatively.<xref rid="wjo287-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Additionally, MMA has been shown to promote better pain control at outpatient follow&#8208;up and reduce hospital readmissions in patients undergoing surgery.<xref rid="wjo287-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="wjo287-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> While Eggerstedt et al.<xref rid="wjo287-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> mentioned providing discharge instructions for tapering gabapentin to patients, specific guidelines on how to taper gabapentin postoperatively in the head and neck free flap patient population is&#160;yet to be described. Abrupt discontinuation of centrally acting medication such as gabapentin is discouraged; however, there are no specific recommendations for tapering off gabapentin. Factors such as how long the patient takes the drug, how large the dose is, and physiological factors such as age, gender, and body weight are all important to consider.<xref rid="wjo287-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Some studies, however, state that for patients who are on gabapentin for a short period of time, tapering could be done in the span of 3&#8211;7 days.<xref rid="wjo287-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="wjo287-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="wjo287-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> At our center, we recommend gabapentin be tapered by 150&#8201;mg daily in the span of 5 days postdischarge (if patients were receiving gabapentin three times daily as inpatients) or be tapered in 1 day with a total dose of 150&#8201;mg (if patients were receiving gabapentin once daily as inpatients). Additionally, we discharge patients at our center with acetaminophen to be used as needed, as well as a 5&#8208;day supply of celecoxib (Table&#160;<xref rid="wjo287-tbl-0004" ref-type="table">4</xref>). Further investigation is required to determine the efficacy of this regimen in this patient population compared to patients receiving narcotics for pain control.</p><table-wrap position="float" id="wjo287-tbl-0004" content-type="Table" orientation="portrait"><label>Table 4</label><caption><p>Multimodal analgesia protocol</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="bottom" rowspan="1" colspan="1">Gabapentin</th><th align="left" valign="bottom" rowspan="1" colspan="1">Acetaminophen</th><th align="left" valign="bottom" rowspan="1" colspan="1">Ketorolac</th><th align="left" valign="bottom" rowspan="1" colspan="1">Celecoxib</th><th align="left" valign="bottom" rowspan="1" colspan="1">Fentanyl/other opioid</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Preoperative</td><td valign="top" rowspan="1" colspan="1">
<p>900&#8201;mg<xref rid="wjo287-tbl4-note-0002" ref-type="table-fn">a</xref> PO</p>
<p>OR</p>
<p>300&#8201;mg<xref rid="wjo287-tbl4-note-0003" ref-type="table-fn">b</xref> PO</p>
</td><td valign="top" rowspan="1" colspan="1">1000&#8201;mg PO&#8201;&#215;&#8201;1</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intraoperative</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1000&#8201;mg IV&#8201;&#215;&#8201;1</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postoperative</td><td valign="top" rowspan="1" colspan="1">
<p>300&#8201;mg<xref rid="wjo287-tbl4-note-0004" ref-type="table-fn">c</xref> PO/DHT TID</p>
<p>OR</p>
<p>300&#8201;mg<xref rid="wjo287-tbl4-note-0005" ref-type="table-fn">d</xref> PO/DHT QD</p>
</td><td valign="top" rowspan="1" colspan="1">650&#8201;mg PO/DHT q6h</td><td valign="top" rowspan="1" colspan="1">15&#8201;mg<xref rid="wjo287-tbl4-note-0006" ref-type="table-fn">e</xref> IV q6h&#160;PRN (for 4&#8211;6 pain) for 72&#8201;h</td><td valign="top" rowspan="1" colspan="1">200&#8201;mg<xref rid="wjo287-tbl4-note-0007" ref-type="table-fn">f</xref> PO/DHT q12h</td><td valign="top" rowspan="1" colspan="1">PRN<xref rid="wjo287-tbl4-note-0008" ref-type="table-fn">g</xref> fentanyl 24&#8211;48&#8201;h postoperatively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Discharge</td><td valign="top" rowspan="1" colspan="1">
<p>Day&#160;1<xref rid="wjo287-tbl4-note-0009" ref-type="table-fn">h</xref>: 750&#8201;mg</p>
<p>Day 2: 600&#8201;mg</p>
<p>Day 3: 450&#8201;mg</p>
<p>Day 4: 300&#8201;mg</p>
<p>Day 5: 150&#8201;mg</p>
<p>OR</p>
<p>Day 1<xref rid="wjo287-tbl4-note-0011" ref-type="table-fn">i</xref>: 150&#8201;mg</p>
</td><td valign="top" rowspan="1" colspan="1">650&#8201;mg q6h PO/PEG q6h PRN</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">5&#8208;day<xref rid="wjo287-tbl4-note-0011" ref-type="table-fn">j</xref> supply</td><td valign="top" rowspan="1" colspan="1">PRN</td></tr></tbody></table><table-wrap-foot><fn id="wjo287-tbl4-note-0001"><p>Abbreviations: DHT, ingestion through Dobhoff tube; GFR, glomerular filtration rate;&#160;</p><p>PEG, ingestion through PEG tube; PO, oral; TID, three timeas a day.</p></fn><fn id="wjo287-tbl4-note-0002"><label>
<sup>a</sup>
</label><p>If GFR&#8201;&gt;&#8201;79&#8201;ml/min.</p></fn><fn id="wjo287-tbl4-note-0003"><label>
<sup>b</sup>
</label><p>If GFR&#8201;&lt;&#8201;79&#8201;ml/min.</p></fn><fn id="wjo287-tbl4-note-0004"><label>
<sup>c</sup>
</label><p>If GFR&#8201;&gt;&#8201;30&#8201;ml/min.</p></fn><fn id="wjo287-tbl4-note-0005"><label>
<sup>d</sup>
</label><p>If GFR&#8201;&lt;&#8201;30&#8201;ml/min.</p></fn><fn id="wjo287-tbl4-note-0006"><label>
<sup>e</sup>
</label><p>If GFR&#8201;&gt;&#8201;50&#8201;ml/min.</p></fn><fn id="wjo287-tbl4-note-0007"><label>
<sup>f</sup>
</label><p>If no history of liver, kidney, or heart failure.</p></fn><fn id="wjo287-tbl4-note-0008"><label>
<sup>g</sup>
</label><p>If history of chronic opioid use.</p></fn><fn id="wjo287-tbl4-note-0009"><label>
<sup>h</sup>
</label><p>If getting 300&#8201;mg TID while inpatient, proceed with 5&#8208;day taper.</p></fn><fn id="wjo287-tbl4-note-0010"><label>
<sup>i</sup>
</label><p>If getting 300&#8201;mg once daily while inpatient, proceed with 1&#8208;day taper.</p></fn><fn id="wjo287-tbl4-note-0011"><label>
<sup>j</sup>
</label><p>If receiving while inpatient.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>While opioids are effective analgesics for postoperative pain, opioid usage postoperatively continues to be significant in patients undergoing head and neck free flap surgery. Further investigation is needed into interventions that reduce continued postoperative opioid use while improving pain control.</p><p>Our study is not without limitations. Our primary outcome of postoperative pain is reliant on a patient's subjective experience with pain, which is multifaceted and difficult to standardize. The use of medication reconciliation for evaluation of continued outpatient opioid use without verifying with a pill count raises the possibility that outpatient use could have been over or underestimated. Additionally, the retrospective nature of this cohort study produces a bias in data availability and collection. Lastly, while we do make suggestions on an MMA protocol that may provide equal efficacy in postoperative pain control for patients receiving head and neck reconstruction, further comparative data is necessary to demonstrate its effectiveness.</p></sec><sec sec-type="conclusions" id="wjo287-sec-0090"><title>CONCLUSION</title><p>Patients undergoing head and neck free flap surgery usually experience postoperative pain that tends to be managed with opioids, which are often overprescribed by their providers. Our results indicate that in this patient population, overprescribing opioids postoperatively contributes to extended postoperative opioid usage, especially in opioid&#8208;na&#239;ve patients. Furthermore, a poor association between the MEDs administered postoperatively and patients&#8217; reported pain indicates a possible role for nonopioid analgesics. Given that clinician prescriptions strongly contribute to the opioid epidemic by creating a household supply without necessarily improving postoperative pain control, it is imperative to further investigate the role of MMA in this patient population to eliminate unnecessary narcotic provision to patients at risk of opioid dependence.</p></sec><sec id="wjo287-sec-0100"><title>AUTHOR CONTRIBUTIONS</title><p>All listed authors in this manuscript have made substantial contributions to the conception and design, or acquisition of data, or analysis and interpretation of data; they have&#160;been involved in drafting the manuscript or revising it critically for important intellectual content, and they have given final approval of the version to be published. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p></sec><sec sec-type="COI-statement" id="wjo287-sec-0120"><title>CONFLICT OF INTEREST</title><p>The authors declare no conflict&#160;of interest.</p></sec><sec id="wjo287-sec-0150"><title>ETHICS STATEMENT</title><p>This material is the authors&#8217; own original work, which has not been previously published elsewhere. The paper is not currently being considered for publication elsewhere. The paper reflects the authors&#8217; own research and analysis in a truthful and complete manner.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="wjo287-suppl-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="WJO2-9-153-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="wjo287-sec-0110"><title>ACKNOWLEDGMENT</title><p>We would like to thank all authors for their thoughtful contributions to this manuscript. No financial support was provided for this article.</p></ack><sec sec-type="data-availability" id="wjo287-sec-0140"><title>DATA AVAILABILITY STATEMENT</title><p>Data used for this study are&#160;not publicly available but accessible upon reasonable request.</p></sec><ref-list content-type="cited-references" id="wjo287-bibl-0001"><title>REFERENCES</title><ref id="wjo287-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="wjo287-cit-0001"><string-name name-style="western"><surname>Bianchini</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Malag&#242;</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Crema</surname><given-names>L</given-names></string-name>, et al. <article-title>Dolore post&#8208;operatorio nei pazienti affetti da neoplasia testa&#8208;collo: fattori predittivi ed efficacia della terapia</article-title>. <source>Acta Otorhinolaryngol Ital</source>. <year>2016</year>;<volume>36</volume>:<fpage>91</fpage>&#8208;<lpage>96</lpage>.<pub-id pub-id-type="pmid">27196072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14639/0392-100X-499</pub-id><pub-id pub-id-type="pmcid">PMC4907166</pub-id></mixed-citation></ref><ref id="wjo287-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="wjo287-cit-0002"><string-name name-style="western"><surname>Go</surname><given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Go</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Chorath</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Moreira</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rajasekaran</surname><given-names>K</given-names></string-name>. <article-title>Multimodal analgesia in head and neck free flap reconstruction: a systematic review</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2022</year>;<volume>166</volume>:<fpage>820</fpage>&#8208;<lpage>831</lpage>.<pub-id pub-id-type="pmid">34372726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/01945998211032910</pub-id></mixed-citation></ref><ref id="wjo287-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="wjo287-cit-0003"><string-name name-style="western"><surname>Hinther</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nakoneshny</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Chandarana</surname><given-names>SP</given-names></string-name>, <string-name name-style="western"><surname>Wayne Matthews</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Dort</surname><given-names>JC</given-names></string-name>. <article-title>Efficacy of postoperative pain management in head and neck cancer patients</article-title>. <source>J Otolaryngol Head Neck Surg</source>. <year>2018</year>;<volume>47</volume>:<fpage>29</fpage>.<pub-id pub-id-type="pmid">29720267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40463-018-0274-y</pub-id><pub-id pub-id-type="pmcid">PMC5932752</pub-id></mixed-citation></ref><ref id="wjo287-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="wjo287-cit-0004"><string-name name-style="western"><surname>Hinther</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rasool</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nakoneshny</surname><given-names>SC</given-names></string-name>, et al. <article-title>Chronic opioid use following surgery for head and neck cancer patients undergoing free flap reconstruction</article-title>. <source>J Otolaryngol Head Neck Surg</source>. <year>2021</year>;<volume>50</volume>:<fpage>28</fpage>.<pub-id pub-id-type="pmid">33892825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40463-021-00508-y</pub-id><pub-id pub-id-type="pmcid">PMC8066487</pub-id></mixed-citation></ref><ref id="wjo287-bib-0005"><label>5</label><mixed-citation publication-type="book" id="wjo287-cit-0005"><collab collab-type="authors">Centers for Disease Control and Prevention</collab>
. <source>Prescription Opioids Overview. Opioid Overdose</source>. <publisher-name>Centers for Disease Control and Prevention</publisher-name>; <year>2020</year>.</mixed-citation></ref><ref id="wjo287-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="wjo287-cit-0006"><string-name name-style="western"><surname>Jones</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Paulozzi</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Mack</surname><given-names>KA</given-names></string-name>. <article-title>Sources of prescription opioid pain relievers by frequency of past&#8208;year nonmedical use United States, 2008&#8208;2011</article-title>. <source>JAMA Intern Med</source>. <year>2014</year>;<volume>174</volume>:<fpage>802</fpage>&#8208;<lpage>803</lpage>.<pub-id pub-id-type="pmid">24589763</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2013.12809</pub-id><pub-id pub-id-type="pmcid">PMC6688495</pub-id></mixed-citation></ref><ref id="wjo287-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="wjo287-cit-0007"><string-name name-style="western"><surname>Svider</surname><given-names>PF</given-names></string-name>, <string-name name-style="western"><surname>Arianpour</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>E</given-names></string-name>, et al. <article-title>Opioid prescribing patterns among otolaryngologists: crucial insights among the medicare population</article-title>. <source>Laryngoscope</source>. <year>2018</year>;<volume>128</volume>:<fpage>1576</fpage>&#8208;<lpage>1581</lpage>.<pub-id pub-id-type="pmid">29446449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/lary.27101</pub-id></mixed-citation></ref><ref id="wjo287-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="wjo287-cit-0008"><string-name name-style="western"><surname>Schwartz</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Naples</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Kuo</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Falcone</surname><given-names>TE</given-names></string-name>. <article-title>Opioid prescribing patterns among otolaryngologists</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2018</year>;<volume>158</volume>:<fpage>854</fpage>&#8208;<lpage>859</lpage>.<pub-id pub-id-type="pmid">29460670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0194599818757959</pub-id></mixed-citation></ref><ref id="wjo287-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="wjo287-cit-0009"><string-name name-style="western"><surname>Biskup</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dzioba</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sowerby</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Monteiro</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Strychowsky</surname><given-names>J</given-names></string-name>. <article-title>Opioid prescribing practices following elective surgery in Otolaryngology&#8208;Head &amp; Neck Surgery</article-title>. <source>J Otolaryngol Head Neck Surg</source>. <year>2019</year>;<volume>48</volume>:<fpage>29</fpage>.<pub-id pub-id-type="pmid">31234932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40463-019-0352-9</pub-id><pub-id pub-id-type="pmcid">PMC6591868</pub-id></mixed-citation></ref><ref id="wjo287-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="wjo287-cit-0010"><string-name name-style="western"><surname>Chou</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Fanciullo</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Fine</surname><given-names>PG</given-names></string-name>, et al. <article-title>Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain</article-title>. <source>J&#160;Pain</source>. <year>2009</year>;<volume>10</volume>:<fpage>113</fpage>&#8208;<lpage>130.e22</lpage>.<pub-id pub-id-type="pmid">19187889</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpain.2008.10.008</pub-id><pub-id pub-id-type="pmcid">PMC4043401</pub-id></mixed-citation></ref><ref id="wjo287-bib-0011"><label>11</label><mixed-citation publication-type="book" id="wjo287-cit-0011"><string-name name-style="western"><surname>Anekar</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Cascella</surname><given-names>M</given-names></string-name>. <part-title>WHO analgesic ladder</part-title>. <source>StatPearls [Internet]</source>. <publisher-name>StatPearls Publishing</publisher-name>; <year>2022</year>. Accessed May 15, 2022. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK554435/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK554435/</ext-link><pub-id pub-id-type="pmid">32119322</pub-id></mixed-citation></ref><ref id="wjo287-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="wjo287-cit-0012"><string-name name-style="western"><surname>Willingham</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rangrass</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Curcuru</surname><given-names>C</given-names></string-name>, et al. <article-title>Association between postoperative complications and lingering post&#8208;surgical pain: an observational cohort study</article-title>. <source>Br J Anaesth</source>. <year>2020</year>;<volume>124</volume>:<fpage>214</fpage>&#8208;<lpage>221</lpage>.<pub-id pub-id-type="pmid">31771788</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bja.2019.10.012</pub-id></mixed-citation></ref><ref id="wjo287-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="wjo287-cit-0013"><string-name name-style="western"><surname>Gil</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>DB</given-names></string-name>, <string-name name-style="western"><surname>Marouani</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Khafif</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Fliss</surname><given-names>DM</given-names></string-name>. <article-title>Treatment of pain after head and neck surgeries: control of acute pain after head and neck oncological surgeries</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2006</year>;<volume>135</volume><issue>2</issue>:<fpage>182</fpage>&#8208;<lpage>188</lpage>.<pub-id pub-id-type="pmid">16890065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.otohns.2006.03.005</pub-id></mixed-citation></ref><ref id="wjo287-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="wjo287-cit-0014"><string-name name-style="western"><surname>Helander</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Webb</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Bias</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Whang</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Kaye</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Urman</surname><given-names>RD</given-names></string-name>. <article-title>A comparison of multimodal analgesic approaches in institutional enhanced recovery after surgery protocols for colorectal surgery: pharmacological agents</article-title>. <source>J&#160;Laparoendosc Adv Surg Tech A</source>. <year>2017</year>;<volume>27</volume>:<fpage>903</fpage>&#8208;<lpage>908</lpage>.<pub-id pub-id-type="pmid">28742427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/lap.2017.0338</pub-id></mixed-citation></ref><ref id="wjo287-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="wjo287-cit-0015"><string-name name-style="western"><surname>Elia</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Lysakowski</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Tram&#232;r</surname><given-names>MR</given-names></string-name>. <article-title>Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase&#8208;2 inhibitors and patient&#8208;controlled analgesia morphine offer advantages over morphine alone?</article-title><source>Anesthesiology</source>. <year>2005</year>;<volume>103</volume>:<fpage>1296</fpage>&#8208;<lpage>1304</lpage>.<pub-id pub-id-type="pmid">16306743</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000542-200512000-00025</pub-id></mixed-citation></ref><ref id="wjo287-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="wjo287-cit-0016"><string-name name-style="western"><surname>Carpenter</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Shepherd</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>McCrary</surname><given-names>H</given-names></string-name>, et al. <article-title>Association of celecoxib use with decreased opioid requirements after head and neck cancer surgery with free tissue reconstruction</article-title>. <source>JAMA Otolaryngol Head Neck Surg</source>. <year>2018</year>;<volume>144</volume>:<fpage>988</fpage>&#8208;<lpage>994</lpage>.<pub-id pub-id-type="pmid">29710229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoto.2018.0284</pub-id><pub-id pub-id-type="pmcid">PMC11849744</pub-id></mixed-citation></ref><ref id="wjo287-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="wjo287-cit-0017"><string-name name-style="western"><surname>Chiu</surname><given-names>TW</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Lau</surname><given-names>EY</given-names></string-name>, <string-name name-style="western"><surname>Burd</surname><given-names>A</given-names></string-name>. <article-title>Analgesic effects of preoperative gabapentin after tongue reconstruction with the anterolateral thigh flap</article-title>. <source>Hong Kong Med J</source>. <year>2012</year>;<volume>18</volume>:<fpage>30</fpage>&#8208;<lpage>34</lpage>.<pub-id pub-id-type="pmid">22302908</pub-id></mixed-citation></ref><ref id="wjo287-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="wjo287-cit-0018"><string-name name-style="western"><surname>Lee</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Yi</surname><given-names>DI</given-names></string-name>, <string-name name-style="western"><surname>Prasanna</surname><given-names>PD</given-names></string-name>, <string-name name-style="western"><surname>Kandl</surname><given-names>C</given-names></string-name>. <article-title>Opioid sparing multimodal analgesia treats pain after head and neck microvascular reconstruction</article-title>. <source>Laryngoscope</source>. <year>2020</year>;<volume>130</volume>:<fpage>1686</fpage>&#8208;<lpage>1691</lpage>.<pub-id pub-id-type="pmid">31765034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/lary.28402</pub-id></mixed-citation></ref><ref id="wjo287-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="wjo287-cit-0019"><string-name name-style="western"><surname>Eggerstedt</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Stenson</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Ramirez</surname><given-names>EA</given-names></string-name>, et al. <article-title>Association of perioperative opioid&#8208;sparing multimodal analgesia with narcotic use and pain control after head and neck free flap reconstruction</article-title>. <source>JAMA Facial Plast Surg</source>. <year>2019</year>;<volume>21</volume>:<fpage>446</fpage>&#8208;<lpage>451</lpage>.<pub-id pub-id-type="pmid">31393513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamafacial.2019.0612</pub-id><pub-id pub-id-type="pmcid">PMC6692678</pub-id></mixed-citation></ref><ref id="wjo287-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="wjo287-cit-0020"><string-name name-style="western"><surname>Sayal</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Militsakh</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Aurit</surname><given-names>S</given-names></string-name>, et al. <article-title>Association of multimodal analgesia with perioperative safety and opioid use following head and neck microvascular reconstruction</article-title>. <source>Head Neck</source>. <year>2020</year>;<volume>42</volume>:<fpage>2887</fpage>&#8208;<lpage>2895</lpage>.<pub-id pub-id-type="pmid">32686254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hed.26341</pub-id></mixed-citation></ref><ref id="wjo287-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="wjo287-cit-0021"><string-name name-style="western"><surname>Schleiffarth</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Bayon</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Van Daele</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Pagedar</surname><given-names>NA</given-names></string-name>. <article-title>Ketorolac after free tissue transfer: a comparative effectiveness study</article-title>. <source>Ann Otol Rhinol Laryngol</source>. <year>2014</year>;<volume>123</volume>:<fpage>446</fpage>&#8208;<lpage>449</lpage>.<pub-id pub-id-type="pmid">24690984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0003489414526849</pub-id></mixed-citation></ref><ref id="wjo287-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="wjo287-cit-0022"><string-name name-style="western"><surname>Smith</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Lange</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Eid</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Monico</surname><given-names>J</given-names></string-name>. <article-title>The role of intravenous acetaminophen in post&#8208;operative pain control in head and neck cancer patients</article-title>. <source>Laryngoscope Investig Otolaryngol</source>. <year>2019</year>;<volume>4</volume>:<fpage>250</fpage>&#8208;<lpage>254</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/lio2.254</pub-id><pub-id pub-id-type="pmcid">PMC6476265</pub-id><pub-id pub-id-type="pmid">31024996</pub-id></mixed-citation></ref><ref id="wjo287-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="wjo287-cit-0023"><string-name name-style="western"><surname>Townsend</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liou</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kallogjeri</surname><given-names>D</given-names></string-name>, et al. <article-title>Effect of perioperative gabapentin use on postsurgical pain in patients undergoing head and neck mucosal surgery: a randomized clinical trial</article-title>. <source>JAMA Otolaryngol Head Neck Surg</source>. <year>2018</year>;<volume>144</volume>:<fpage>959</fpage>&#8208;<lpage>966</lpage>.<pub-id pub-id-type="pmid">29710075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoto.2018.0282</pub-id><pub-id pub-id-type="pmcid">PMC6248193</pub-id></mixed-citation></ref><ref id="wjo287-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="wjo287-cit-0024"><string-name name-style="western"><surname>Vu</surname><given-names>CN</given-names></string-name>, <string-name name-style="western"><surname>Lewis</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Bailard</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Kapoor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rubin</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>G</given-names></string-name>. <article-title>Association between multimodal analgesia administration and perioperative opioid requirements in patients undergoing head and neck surgery with free flap reconstruction</article-title>. <source>JAMA Otolaryngol Head Neck Surg</source>. <year>2020</year>;<volume>146</volume>:<fpage>708</fpage>&#8208;<lpage>713</lpage>.<pub-id pub-id-type="pmid">32556065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoto.2020.1170</pub-id><pub-id pub-id-type="pmcid">PMC7303891</pub-id></mixed-citation></ref><ref id="wjo287-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="wjo287-cit-0025"><string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bai</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></string-name>. <article-title>Efficacy and safety of lower extremity nerve blocks for postoperative analgesia at free fibular flap donor sites</article-title>. <source>Head Neck</source>. <year>2018</year>;<volume>40</volume>:<fpage>2670</fpage>&#8208;<lpage>2676</lpage>.<pub-id pub-id-type="pmid">30387900</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hed.25470</pub-id></mixed-citation></ref><ref id="wjo287-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="wjo287-cit-0026"><string-name name-style="western"><surname>Chang</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Challa</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Shah</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Eloy</surname><given-names>JD</given-names></string-name>. <article-title>Gabapentin in acute postoperative pain management</article-title>. <source>BioMed Res Int</source>. <year>2014</year>;<volume>2014</volume>:<fpage>1</fpage>&#8208;<lpage>7</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/631756</pub-id><pub-id pub-id-type="pmcid">PMC4009126</pub-id><pub-id pub-id-type="pmid">24829909</pub-id></mixed-citation></ref><ref id="wjo287-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="wjo287-cit-0027"><string-name name-style="western"><surname>Hah</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mackey</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>P</given-names></string-name>, et al. <article-title>Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial</article-title>. <source>JAMA Surgery</source>. <year>2018</year>;<volume>153</volume>:<fpage>303</fpage>&#8208;<lpage>311</lpage>.<pub-id pub-id-type="pmid">29238824</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2017.4915</pub-id><pub-id pub-id-type="pmcid">PMC5933381</pub-id></mixed-citation></ref><ref id="wjo287-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="wjo287-cit-0028"><string-name name-style="western"><surname>Desai</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Carroll</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Asch</surname><given-names>SM</given-names></string-name>, et al. <article-title>Utilization and effectiveness of multimodal discharge analgesia for postoperative pain management</article-title>. <source>J Surg Res</source>. <year>2018</year>;<volume>228</volume>:<fpage>160</fpage>&#8208;<lpage>169</lpage>.<pub-id pub-id-type="pmid">29907207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jss.2018.03.029</pub-id><pub-id pub-id-type="pmcid">PMC6476628</pub-id></mixed-citation></ref><ref id="wjo287-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="wjo287-cit-0029"><string-name name-style="western"><surname>Freynhagen</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Baron</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kawaguchi</surname><given-names>Y</given-names></string-name>, et al. <article-title>Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration</article-title>. <source>Postgrad Med</source>. <year>2021</year>;<volume>133</volume>:<fpage>1</fpage>&#8208;<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00325481.2020.1857992</pub-id><pub-id pub-id-type="pmid">33423590</pub-id></mixed-citation></ref><ref id="wjo287-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="wjo287-cit-0030"><string-name name-style="western"><surname>Ben&#8208;Menachem</surname><given-names>E</given-names></string-name>. <article-title>Pregabalin pharmacology and its relevance to clinical practice</article-title>. <source>Epilepsia</source>. <year>2004</year>;<volume>45</volume>:<fpage>13</fpage>&#8208;<lpage>18</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.0013-9580.2004.455003.x</pub-id><pub-id pub-id-type="pmid">15315511</pub-id></mixed-citation></ref><ref id="wjo287-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="wjo287-cit-0031"><string-name name-style="western"><surname>Bockbrader</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Wesche</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chapel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Janiczek</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Burger</surname><given-names>P</given-names></string-name>. <article-title>A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin</article-title>. <source>Clin Pharmacokinet</source>. <year>2010</year>;<volume>49</volume>:<fpage>661</fpage>&#8208;<lpage>669</lpage>.<pub-id pub-id-type="pmid">20818832</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/11536200-000000000-00000</pub-id></mixed-citation></ref><ref id="wjo287-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="wjo287-cit-0032"><string-name name-style="western"><surname>Bockbrader</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Radulovic</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Posvar</surname><given-names>EL</given-names></string-name>, et al. <article-title>Clinical pharmacokinetics of pregabalin in healthy volunteers</article-title>. <source>J Clin Pharmacol</source>. <year>2010</year>;<volume>50</volume>:<fpage>941</fpage>&#8208;<lpage>950</lpage>.<pub-id pub-id-type="pmid">20147618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0091270009352087</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>